A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
Clinical trial NCT07143045 · RECRUITING
Trial details
- NCT number
- NCT07143045
- Sponsor
- Alpha Biopharma (Jiangsu) Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-29
- Primary completion
- 2031-05-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.